Cell Targeting Technology

Arch Has Received US Patent for Its Brain Tumor Cell Targeting Technology
Sep 16, 2013
Arch Biopartners (Arch) has received US patent for its brain tumor cell targeting technology, which protects novel synthetic peptides that target and attach human brain tumor initiating cells (BTICs) and invasive glioma cells (IGCs). The ...

Tags: Arch Biopartners, Cell Targeting Technology